15 March 2021
In this application note, The Jackson Laboratory demonstrate how the cord blood CD34+ hematopoietic stem cell (HSC) humanized NSG™-IL15 mouse enables
in vivo efficacy research for compounds targeting human natural killer (NK) cell activity including antibody-dependent cellular cytotoxicity (ADCC).
Download 10,000+